TrialJNCI cancer spectrum2021

Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial.

Karen J Wernli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.